Researchers have found that a blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are suffering from relapse.'Being able to spot the first signs of relapse so we can rapidly decide the best treatment strategy is an important area for research' said lead study author Richard Marais skin cancer expert at Cancer Research UK a leading cancer charity dedicated to saving lives through research. 'Using our technique we hope that one day we will be able to spot when a patient's disease is coming back at the earliest point and start treatment
